Robust statistical evaluation of tumor incidences in long-term rodent carcinogenicity studies: the reformulated poly-k trend test
Abstract
Mortality-adjusted tumor rates in long-term carcinogenicity rodent bioassays are commonly evaluated by means of the poly-k=3 Armitage trend test. However, this assumes exactly a linear dose-response curve and the Weibull parameter of k=3 for all tumor sites. These unrealistic assumptions can be circumvented by multiple testing across multiple possible dose-response shapes, multiple Weibull parameters, multiple effect sizes, multiple correlated tumors as well as pairwise and trend tests using the multiple marginal models approach. Based on data examples, different multiple tests are demonstrated using the CRAN R packages multcomp, tukeytrend, coin, MCPAN and multfisher.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Statistical notes on false positive and negative error rates in the evaluation of long-term carcinogenicity bioassays
Ludwig A. Hothorn·bioRxiv·Feb 25, 2022
- Testing monotonic trends among multiple group means against a composite null
Chenxiao Hu, Thomas J. Sharpton, Duo Jiang·bioRxiv·May 28, 2020
- Mathematical models of tumor volume dynamics in response to radiotherapy
N. Mohsin, H. U. Enderling, … M. U. Zahid·bioRxiv·Apr 7, 2022
- Statistical approach for ...a test chemical is considered to be positive... in regulatory toxicology: Trend and pairwise tests
L. A. Hothorn·bioRxiv·Nov 29, 2019
- Beneficial Effects Of Ketogenic Diets For Cancer Patients - A Realist Review With Focus On Evidence And Confirmation
R. J. Klement·bioRxiv·Jun 2, 2017
- Graded NTCP dynamics: leveraging patient-reported outcomes to explore response and cross-toxicity trade-offs in head and neck cancer
Daniel J. Glazar, Ryan Werthmann, … Renee Brady‐Nicholls·bioRxiv·Oct 13, 2025